Actym Therapeutics Announces Significant Expansion of Senior Leadership

/PRNewswire/ -- Actym Therapeutics, a privately held biotechnology company developing STACT, a novel therapeutic platform that delivers immunomodulatory...

Related Keywords

Stanford University ,California ,United States ,Essex ,Berkeley ,South Korea ,Korea ,Julie Cherrington ,Santa Barbara ,Omkar Joshi ,James Stutz ,Christopher Thanos ,Alios Biopharma ,Drug Product Process Development ,School Of Medicine ,Boards Of Syncona Ltd ,Janssen Pharmaceutical Companies Of Johnson ,Preclinical Research ,Clinical Research ,University Of Minnesota ,Lecturer At Stanford University ,Manufacturing Sciences ,Department Of Medicine ,Oregon State University ,Tuck School Of Business At Dartmouth ,Actym Therapeutics Inc ,Gilead Sciences ,Boehringer Ingelheim Venture Fund ,United States Air ,Strategy Business Development ,Phenomix Corporation ,Leadership Team ,Head Of Business Development At Instil Bio ,Actym Executive Leadership Team ,Essex Woodlands Health Ventures ,Division Of Clinical Pharmacology ,Analytical Development ,Chief Business Officer ,Vice President ,Executive Leadership Team ,Cherrington Phd ,Chief Executive Officer ,Arch Oncology ,Revitope Oncology ,Zenith Epigenetics ,Executive Vice President ,Syncona Ltd ,Sardona Therapeutics ,Kisoji Biotechnology ,Chief Business ,Business Development ,Chief Financial Officer ,Janssen Pharmaceutical Companies ,Revance Therapeutics ,Tuck School ,Clinical Pharmacology ,Joshi Phd ,Senior Director ,Drug Substance ,Chemical Engineering ,Oregon State ,Technical Operations ,Attenuated Cancer Therapy ,Panacea Venture ,Illumina Ventures ,Korea Investment Partners ,Actym Therapeutics ,